000			01237 a2200349 4500
005			20250515065759.0
264		0	_c20070618
008			200706s 0 0 jpn d
022			_a0301-2603
040			_aNLM _beng _cNLM
100	1		_aNagane, Motoo
245	0	0	_a[Chemotherapy for malignant gliomas]. _h[electronic resource]
260			_bNo shinkei geka. Neurological surgery _cMay 2007
300			_a433-50 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBlood-Brain Barrier
650	0	4	_aBrain Neoplasms _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aDNA Modification Methylases _xtherapeutic use
650	0	4	_aDNA Repair
650	0	4	_aDNA Repair Enzymes _xtherapeutic use
650	0	4	_aDacarbazine _xadministration & dosage
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aGlioma _xdrug therapy
650	0	4	_aHumans
650	0	4	_aNitroso Compounds _xtherapeutic use
650	0	4	_aSurvival Rate
650	0	4	_aTemozolomide
650	0	4	_aTumor Suppressor Proteins _xtherapeutic use
773	0		_tNo shinkei geka. Neurological surgery _gvol. 35 _gno. 5 _gp. 433-50
999			_c17036870 _d17036870